Joo KW, Kim S, Ahn SY, Chin HJ, Chae DW, Lee J, et al
According to an FDA statement provided to Reuters, inspectors conducted normal pre-approval and routine inspections. The statement also noted that Novo Nordisk responded with information describing corrective actions. At this time, the agency reportedly communicated, based on the FDAs inspections and the companys responses to the inspectional observations, the FDA does not have information that suggests ongoing compliance issues that raise concerns about the quality of drug products manufactured at the site. Did you or a loved one suffer from severe gastroparesis, ileus or intestinal obstruction after taking Ozempic
Chang H, Kuo C-F, Yu T-S, Ke L-Y, Hung C-L, Tsai S-Y
What Is the Mental Health Parity and Addiction Equity Act